Table 2. Two- and five-year survival outcomes following CRS+HIPEC vs SC alone.
|
Survival
(%) |
|||
---|---|---|---|---|
Treatment protocol | Mahteme et al, 2004 | Verwaal et al, 2008 | Elias et al, 2009 | Franko et al, 2010 |
2 Years | ||||
SC | 10 | 22 | 65 | 41 |
CRS+HIPEC |
60 |
40 |
81 |
66 |
5 Years | ||||
SC | 5 | 10 | 13 | 5 |
CRS+HIPEC | 28 | 19 | 51 | 26 |
Abbreviations: CRS=cytoreductive surgery; HIPEC=hyperthermic intraperitoneal chemotherapy; SC=systemic chemotherapy.